Olanzapine Tablet, Orally Disintegrating
Product Images NDC 59746-309

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 59746-309). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Jubilant Cadista Pharmacuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10mgcarton

10mgcarton
Packaging label for Olanzapine Orally Disintegrating Tablets, USP 10 mg by Jubilant Cadista Pharmaceuticals Inc. The label displays unit-dose packaging containing 30 tablets (3x10 unit-dose). It includes usage instructions with illustrations and storage information. The label also shows barcodes, lot number, and expiration date fields, and emphasizes that the tablets are orally disintegrating.*
FDA Label Image

10mgfoil

10mgfoil
A sheet of drug labels for Olanzapine orally disintegrating tablets, USP with a strength of 10 mg. Each label indicates the product as a prescription drug from Jubilant Cadista Pharmaceuticals Inc. The labels include a barcode, the text 'Rx Only', and instructions to pull tabs. The arrangement shows multiple identical labels printed together.*
FDA Label Image

15mgcarton

15mgcarton
Packaging label for Olanzapine Orally Disintegrating Tablets USP 15 mg by Jubilant Cadista Pharmaceuticals Inc. The label shows a 30-tablet unit dose carton with instructions for tablet removal, storage conditions, and dosage information. It includes an image of the Cadista logo and directions to dispense medication guides with each prescription.*
FDA Label Image

15mgfoil

15mgfoil
Label for Olanzapine 15 mg orally disintegrating tablets, distributed by Jubilant Cadista Pharmaceuticals Inc. The label includes the drug name, strength, dosage form, a barcode, and Rx only indication. Multiple identical labels are shown.*
FDA Label Image

20mgcarton

20mgcarton
The packaging label for Olanzapine 20 mg Orally Disintegrating Tablets, USP, shows a 30-tablet count blister pack by Jubilant Cadista Pharmaceuticals Inc. It features the Cadista logo, NDC 59746-309-32, dosage instructions, storage conditions, and manufacturer details including Jubilant Generics Ltd. in India and the U.S. distributor.*
FDA Label Image

20mgfoil

20mgfoil
Packaging label for Olanzapine orally disintegrating tablets, USP, 15 mg strength. The label shows multiple instances of the product name Olanzapine with dosage form and strength, labeled as a prescription drug (Rx only), manufactured by Jubilant Cadista Pharmaceuticals Inc. Each label includes a barcode and lot number information, arranged in a repeating pattern.*
FDA Label Image

5mgcarton

5mgcarton
Packaging label for Olanzapine Orally Disintegrating Tablets USP, 5 mg, containing 30 tablets in a 3x10 unit-dose format. The label includes the brand name Cadista, dosage strength prominently highlighted, and instructions for use. Manufactured by Jubilant Generics Ltd. and marketed by Jubilant Cadista Pharmaceuticals Inc.*
FDA Label Image

5mgfoil

5mgfoil
Label print for Olanzapine 5 mg orally disintegrating tablets by Jubilant Cadista Pharmaceuticals Inc. The label shows the product name, strength (5 mg), dosage form, and manufacturer information, along with barcodes and regulatory markings. Multiple instances of the label are arranged in a sheet format.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagram of the active ingredient Olanzapine, showing its molecular components including a thiophene ring and piperazine moiety with methyl substitutions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.